Zhongzhu Healthcare Holding (600568) Fundamentals 2026 — Revenue Analysis | SniperIQ
Zhongzhu Healthcare Holding (600568) is a CN-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ¥4.3B, trading at ¥2.16 on the SHH. This SniperIQ fundamentals page covers Zhongzhu Healthcare Holding's valuation, profitability (net margin -21.4%), revenue (¥577M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Zhongzhu Healthcare Holding's market cap?
Zhongzhu Healthcare Holding (600568) has a market capitalization of approximately ¥4.3B, trading at ¥2.16 on the SHH. Market cap moves with the live share price.
What is Zhongzhu Healthcare Holding's P/E ratio?
Zhongzhu Healthcare Holding's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Zhongzhu Healthcare Holding?
Zhongzhu Healthcare Holding runs a net profit margin of -21.4%, a gross margin of 16.4%, and an operating margin of -23.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Zhongzhu Healthcare Holding generate?
Zhongzhu Healthcare Holding reported revenue of ¥577M for fiscal year 2025, with net income of -¥114M and earnings per share (EPS) of -0.0569. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Zhongzhu Healthcare Holding pay a dividend?
Zhongzhu Healthcare Holding does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Zhongzhu Healthcare Holding financially healthy?
Zhongzhu Healthcare Holding carries a debt-to-equity ratio of 0.01x and a current ratio of 3.50x, with a market beta of 0.25. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Zhongzhu Healthcare Holding a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Zhongzhu Healthcare Holding (600568) the key facts are: market cap ¥4.3B, revenue ¥577M, 52-week range 1.6-3.27. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Zhongzhu Healthcare Holding's full fundamentals live
Get Zhongzhu Healthcare Holding's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.